JP2023502998A5 - - Google Patents

Info

Publication number
JP2023502998A5
JP2023502998A5 JP2022528615A JP2022528615A JP2023502998A5 JP 2023502998 A5 JP2023502998 A5 JP 2023502998A5 JP 2022528615 A JP2022528615 A JP 2022528615A JP 2022528615 A JP2022528615 A JP 2022528615A JP 2023502998 A5 JP2023502998 A5 JP 2023502998A5
Authority
JP
Japan
Prior art keywords
composition according
cancer
pharmaceutical composition
tumor
imaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022528615A
Other languages
English (en)
Japanese (ja)
Other versions
JP7752110B2 (ja
JP2023502998A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/060910 external-priority patent/WO2021101905A1/en
Publication of JP2023502998A publication Critical patent/JP2023502998A/ja
Publication of JP2023502998A5 publication Critical patent/JP2023502998A5/ja
Application granted granted Critical
Publication of JP7752110B2 publication Critical patent/JP7752110B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022528615A 2019-11-18 2020-11-17 ｐＨ応答性組成物、製剤、及び腫瘍画像化の方法 Active JP7752110B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962937141P 2019-11-18 2019-11-18
US62/937,141 2019-11-18
PCT/US2020/060910 WO2021101905A1 (en) 2019-11-18 2020-11-17 Ph responsive compositions, formulations, and methods of imaging a tumor

Publications (3)

Publication Number Publication Date
JP2023502998A JP2023502998A (ja) 2023-01-26
JP2023502998A5 true JP2023502998A5 (https=) 2025-06-18
JP7752110B2 JP7752110B2 (ja) 2025-10-09

Family

ID=75980983

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022528615A Active JP7752110B2 (ja) 2019-11-18 2020-11-17 ｐＨ応答性組成物、製剤、及び腫瘍画像化の方法

Country Status (11)

Country Link
US (1) US20230025280A1 (https=)
EP (1) EP4061428A4 (https=)
JP (1) JP7752110B2 (https=)
KR (1) KR20220149906A (https=)
CN (1) CN115279422B (https=)
AU (1) AU2020387279B2 (https=)
BR (1) BR112022009606A2 (https=)
CA (1) CA3158471A1 (https=)
IL (1) IL293101A (https=)
MX (1) MX2022005996A (https=)
WO (1) WO2021101905A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202113178QA (en) * 2019-05-28 2021-12-30 Univ Texas pH RESPONSIVE COMPOSITIONS AND USES THEREOF
WO2025129124A1 (en) * 2023-12-15 2025-06-19 The Board Of Regents Of The University Of Texas System Stimuli-responsive sting-activating polymer compositions and methods of use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE345780T1 (de) * 2001-07-13 2006-12-15 Nanocarrier Co Ltd Lyophilisierende zusammensetzung von wirkstoff- verkapselnder polymer-mizelle und verfahren zu ihrer herstellung
CN103002921A (zh) * 2010-05-14 2013-03-27 马林克罗特有限公司 用于联合的光学成像和治疗的功能性交联纳米结构
DE102010022110A1 (de) * 2010-05-31 2011-12-01 LMU Universität München Department Chemie Cyaninfarbstoffe als Kontrastmittel zur Unterstützung der Augenchirurgie
US9511152B2 (en) * 2012-04-05 2016-12-06 The Board Of Regents Of The University Of Texas System Multicolored pH-activatable fluorescence nanoplatform
AU2015269068A1 (en) * 2014-06-06 2016-12-22 The Board Of Regents Of The University Of Texas System Library of pH responsive polymers and nanoprobes thereof
CN104758247B (zh) * 2015-04-22 2017-11-14 广东工业大学 一种pH响应聚合物混合胶束及其应用
CA3016457A1 (en) * 2016-03-02 2017-09-08 The Board Of Regents Of The University Of Texas System Sting activating nanovaccine for immunotherapy
JP6984909B2 (ja) * 2016-12-23 2021-12-22 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 活性ベースのプローブ化合物、組成物、および使用方法
US20200333357A1 (en) * 2017-11-13 2020-10-22 The Board Of Regents Of The University Of Texas System Novel tfeb pathway agonists for metabolic diseases and ageing
CN108721649B (zh) * 2018-06-26 2021-12-07 武汉凯德维斯生物技术有限公司 一种肿瘤靶向近红外荧光显像剂的设计、合成及应用
SG11202113178QA (en) * 2019-05-28 2021-12-30 Univ Texas pH RESPONSIVE COMPOSITIONS AND USES THEREOF

Similar Documents

Publication Publication Date Title
RU2270003C2 (ru) Лекарственное средство для лечения солидных опухолей на основе паклитаксела, стабилизированного альбумином
CN102264347A (zh) 灌肠制剂及其应用
US12310962B2 (en) Methods and compositions for treating cancer
EP2952184B1 (en) Pharmaceutical formulation for treating pancreatic cancer
JP2001240542A (ja) 肝細胞性腫瘍処置用薬剤
KR20180103039A (ko) 방광암 치료용 제제
JP2020505436A (ja) 腺様嚢胞がんの治療のためのベンゼンスルホンアミド誘導体の医薬組成物
JP2023502998A5 (https=)
AU2024322346A1 (en) Controlled release formulation and minimally invasive method of administration
CN115279422B (zh) pH响应性组合物、调配物和对肿瘤成像的方法
JP2019534305A (ja) 上部尿路上皮癌の治療方法
KR101952805B1 (ko) 혈관차단제를 포함하는 간암 치료용 조성물
Ji et al. Peripancreatic artery ligation and artery infusion chemotherapy for advanced pancreatic carcinoma
EP1596874B1 (en) Method for treating liver cancer by intrahepatic administration of nemorubicin
JP4394334B2 (ja) 脈管病に関する光物理化学的診断・治療薬
JP2002524496A (ja) 肝臓腫瘍治療へのアントラサイクリン誘導体の使用
WO2024084287A1 (en) Composition for near infrared lymphatic imaging and uses and dosages therefor
RU2260434C1 (ru) Способ лечения местнораспространенных форм рака мочевого пузыря
Yamakawa et al. The use of tolonium in the diagnosis of malignant gastric lesions
Kornmann et al. Conversion of locally inoperable primary rectal cancer with multiple liver metastases to an option for cure after local down-staging and hepatic arterial infusion chemotherapy.
US20240197925A1 (en) Functionalized diblock copolymer and its preparation method and application
RU2222261C2 (ru) Способ прицельной внутриорганной химиотерапии больных раком тела матки
Shafik et al. Anal submucosal injection: a novel modality for the treatment of advanced rectal cancer
WO2025130815A1 (zh) 米托蒽醌在制备淋巴示踪剂中的应用
CN121648321A (zh) 靛胭脂在制备治疗恶性肿瘤手术淋巴结示踪药物中的应用